NeuroBo shareholders approve issuance of shares on warrant exercises at Sep 18 special meeting

MetaVia Inc.

Proposal 1 approved: 2,987,855 for, 54,375 against, 71,422 abstentions.
Issuance covers up to 5,089,060 Series A warrants, 7,633,591 Series B warrants, and 127,227 placement agent warrants.
Proposal 2 (adjournment) also approved: 2,997,754 for, 45,209 against, 70,689 abstentions.
Meeting held virtually on September 18, 2024; 3,113,652 shares present or represented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.